ETF comparison
IBB vs IHI
Both Healthcare.
iShares Biotechnology ETF · iShares U.S. Medical Devices ETF
Holdings overlap
1 positions appear in both funds. Buying equal dollars of IBB and IHI would leave roughly 0.1% of each dollar exposed to the same underlying securities.
Side by side
Sub-score comparison
Tracking quality isn't part of the composite — see what we don't score for why.
Cost difference
IHI is 6 bps cheaper than IBB. On a $100,000 position that's about $60/yr more in fees for IBB.
Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with IBB vs IHI.
Top shared holdings
1 shared in total| # | Holding | In IBB | In IHI | Overlap |
|---|---|---|---|---|
| 1 | Novocure Ltd. | 0.10% | 0.15% | 0.10% |
Only in IBB
255 total- BlackRock Funds III 9.66%
- Gilead Sciences, Inc. 7.75%
- Amgen, Inc. 7.51%
- Vertex Pharmaceuticals, Inc. 7.44%
- Regeneron Pharmaceuticals, Inc. 7.21%
- Alnylam Pharmaceuticals, Inc. 3.99%
- Insmed, Inc. 3.20%
- Argenx SE 3.07%
- Biogen, Inc. 2.46%
- Natera, Inc. 2.41%
Only in IHI
46 total- ABBOTT LABORATORIES 16.98%
- INTUITIVE SURGICAL, INC. 15.57%
- STRYKER CORPORATION 10.76%
- MEDTRONIC PUBLIC LIMITED COMPANY 4.62%
- BECTON, DICKINSON AND COMPANY 4.57%
- EDWARDS LIFESCIENCES CORPORATION 4.47%
- IDEXX LABORATORIES, INC. 4.44%
- RESMED INC. 4.43%
- GE HEALTHCARE TECHNOLOGIES INC. 4.40%
- BOSTON SCIENTIFIC CORPORATION 4.28%
Open IBB or IHI at a brokerage
Both funds trade commission-free at major US brokerages.
Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.
Holdings overlap is the sum of min(weight_a, weight_b) over positions
matched on ISIN (CUSIP fallback). Methodology: see
/methodology/.
Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.